| Literature DB >> 29166863 |
Christina M Brock1,2, Manuel Bañó-Polo3, Maria J Garcia-Murria3, Ismael Mingarro3, Maria Esteve-Gasent4.
Abstract
BACKGROUND: The bacterial spirochete Borrelia burgdorferi is the causative agent of the most commonly reported arthropod-borne illness in the United States, Lyme disease. A family of proteins containing von Willebrand Factor A (VWFA) domains adjacent to a MoxR AAA+ ATPase have been found to be highly conserved in the genus Borrelia. Previously, a VWFA domain containing protein of B. burgdorferi, BB0172, was determined to be an outer membrane protein capable of binding integrin α3β1. In this study, the characterization of a new VWFA domain containing membrane protein, BB0173, is evaluated in order to define the location and topology of this multi-spanning membrane protein. In addition, functional predictions are made.Entities:
Keywords: Aerotolerance; Borrelia burgdorferi; MIDAS motif; Transmembrane; vonWillebrand factor a
Mesh:
Substances:
Year: 2017 PMID: 29166863 PMCID: PMC5700661 DOI: 10.1186/s12866-017-1127-y
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Fig. 1Organization and conservation of bb0173. a Schematic demonstrating the similarity between the Bat region of Borrelia burgdorferi (BB), Borrelia hermsii (BH), Leptospira interrogans (LB), Leptospira biflexa (LBF), and Bacteroides fragilis (BF). Note the similarities across BB0172 through BB0176. b Map demonstrating the pertinent domains of BB0173. The map demonstrates the three transmembrane domains (amino acids: 7–25, 57–77, 310–328), VWFA domain (amino acids: 87–328), MIDAS motif (amino acids: 99–103), BatA domain (amino acids: 9–86), and N-glycosylation sites (amino acids 170–172, 265–267). Additionally, a 30-mer peptide is denoted, BB0173pep, which was used to generate chicken anti-BB0173 antibodies. BB0173T, the truncated BB0173 protein, was also used to generate chicken anti-BB0173 antibodies. c Clustal W (v1.83) alignment of B. burgdorferi B31 BB0173 (bold) against homologues in B. burgdorferi ZS7 (BB0173 BbZS7) Borrelia garinii (BG0172), Borrelia afzelii (BAPKO_0175), and the relapsing fever species Borrelia hermsii (BH0173) and Borrelia turicatae (BT0173). Alignments are also made to B. burgdorferi B31 BB0172 (BB0172 B31), which was found to be very similar in sequence and topology. There is also homology seen to Plasmodium falciparum membrane protein TRAP (Pf TRAP) as well as to the human adhesins LFA-1 (hLFA-1) and CD11b (hCD11b). Conserved residues corresponding to the MIDAS motif are highlighted, including the DXSXS as well as the threonine (T) required for MIDAS function
Fig. 2Expression of bb0173 cDNA upon temperature shift. B. burgdorferi B31A3 strain was grown under unfed tick conditions (RT/pH 7.6) to late log phase then shifted to fed tick conditions (37 °C/pH 6.8) before collection of mRNA. The purified mRNA was reverse transcribed to cDNA, and PCR was performed to detect bb0173, flaB, p66, and ospC. Water was used as a negative control (−). a RNA samples were tested for DNA contamination in lanes 3 and 6. Genomic DNA was run in lanes 2 and 5 and served as the positive control. In lanes 1 and 4, cDNA samples were loaded. To confirm functionality of primers, a second genomic DNA sample was applied in lane 7. b The same shifting conditions were used to generate DNA samples as previously. cDNA samples are in lanes 1 and 3, RNA in lanes 2 and 4, and genomic DNA is labeled as (+). Negative control is water, as above. On the left of the figure, the DNA ladder is shown and sizes are denoted in basepairs
Fig. 3Expression of bb0170 to bb0176 under decreased-oxygen conditions. Gene expression of the Bat-like genes is quantified under atmospheric oxygen and decreased oxygen conditions. The expression of each gene is determined by comparing the expression under atmospheric oxygen to the expression under low-oxygen growth conditions after normalization to the endogenous control gene, flaB (ΔCT = Ct (goi) – Ct (ref); where “goi” refers to the gene of interest, and “ref” to the reference gene used in the study). All genes tested were found to increase expression under low-oxygen conditions except for bb0174 and rpoN, which both became undetectable in the low-oxygen condition, as denoted by the diamond (♦). For this experiment, rpoN, rrp1, hpk1, and rrp2 have been included as control genes. Statistical analysis was performed using the Holm-Sidak multiple comparisons test with a 95% confidence interval. Each gene was evaluated in triplicate. *Denotes statistical differences: *P value <0.05, **P value <0.01, ***P value <0.001 and ****P value <0.0001
Fig. 4Insertion of hydrophobic regions of BB0173 into membranes using Lep as model protein. a The HR sequence in each construct is shown together with the predicted G apparent value, which was estimated using the ∆G prediction algorithm available on the Internet (http://dgpred.cbr.su.se/). Glycosylation acceptor site is shown in bold. b Schematic representation of the Lep construct used to report insertion of hydrophobic regions of BB0173 into endoplasmic reticulum membranes. The TM segment under investigation (HR-tested) was introduced into the P2 domain of Lep, flanked by two artificial glycosylation acceptor sites (G1 and G2). Recognition of the tested sequence as a TM domain by the translocon machinery results in the location of only G1 in the luminal side of the ER membrane, preventing G2 glycosylation (left). The Lep chimera will be doubly glycosylated when the sequence being tested is translocated into the lumen of the microsomes (right). c In vitro translation in the presence of membranes of the different Lep constructs. Constructs containing HR1 (residues 7 to 25; lanes 1–3), HR2 (residues 55 to 77; lanes 4–6), HR3 (residues 163 to 185; lanes 7–9) and HR4 (residues 310 to 328; lines 10–12) were translated in the presence (+) and absence (−) of rough microsomes (RM) and proteinase K (PK). Bands of non- glycosylated proteins are indicated by a white dot; singly and doubly glycosylated proteins are indicated by one and two black dots, respectively. In the case of Lep-HR3 construct a triply glycosylated band was observed (lane 8) due to the presence of an acceptor NGS site (residues 169–171) within the (translocated) hydrophobic region. The protected doubly-glycosylated H2/HR3/P2 fragment is indicated by an arrowhead. Control HRs were used to verify sequence translocation (translocated; lanes 13–15)
Fig. 5In vitro analysis of truncated BB0173 constructs. To monitor the membrane orientation of truncated BB0173 molecules a glycosylatable (NSTMSM) tag (white rectangle) was added at position 56 (56mer), 162 (162mer), 278 (278 mer) and 341 (341mer). a Schematic representation of the constructs used in the assay. The position of the glycosylation sites is marked with a Y symbol. The presence of a TM segment identified by the ΔG prediction server (http://dgpred.cbr.su.se/) in each construct and the required linker sequence preceding the glycosylatable tag to allow glycosylation is also included for 341mer truncates. b In vitro translation of the 56mer, 162mer, 278mer and 341mer truncates in the presence (+) or absence (−) of rough microsomes (RM). A white dot marks the non-glycosylated form of the protein while a black dot indicates glycosylation of the C-terminal tag. c In vitro translations in the presence or absence of RM of 162mer truncated constructs were performed bearing an acceptor (NST) or non-acceptor (QST) at N-terminal and/or C-terminal glycosylation tag. White and black dots indicate non-glycosylated and glycosylated molecules respectively, as in panel b. d Schematic representation of the membrane topology of 341mer truncates. A hydrophobic region is noted as a blue box when inserted in the membrane, or as a red box if it is not recognized by the translocon as a TM domain. The position of the glycosylatable tag (white rectangle) and its glycosylation status (white and black dots, represents non-glycosylated and glycosylated respectively) is also shown
Fig. 6Localization of BB0173 to the aqueous and inner membrane fractions after treatment with detergent. B. burgdorferi cells disrupted using the detergent Triton X-114 separated into three distinct fractions, the aqueous (AQ), protoplasmic cylinders (PC), and detergent (DT) phases. The phases were separated using SDS-12% PAGE and either stained using Silver Stain Plus (Biorad, Hercules, CA) (a) or were transferred to a PVDF membrane and probed using anti-BB0173T and a secondary anti-chicken HRP-conjugated antibody Lane 1 is B. burgdorferi whole cell lysate. Lane 2 is AQ, Lane 3 is PC, and Lane 4 is DT (b). Controls for outer membrane and inner membrane proteins were OspC and FlaB
Fig. 7Protection of BB0173 from protease degradation. Surface proteins of B. burgdorferi are degraded by serine protease Proteinase K (PK). Whole cell lysates were treated with doses ranging from 0 to 200 μg/mL PK prior to separation using SDS-12% PAGE. Gels were either visualized using Coomassie blue staining (a) or transferred to a PVDF membrane and probed with antibodies (b). BB0173 was detected using anti-BB0173pep and anti-chicken HRP-conjugated antibody. Controls for PK mediated degradation and cell integrity during treatment included intercellular protein BosR and periplasmic protein FlaB, as well as outer membrane proteins OspC, VlsE, and P66
Fig. 8Localization of the tertiary structures of BB0172 and BB0173 within B. burgdorferi. Models of the tertiary structures of BB0172 and BB0173 were generated and superimposed onto either the inner or outer membrane as predicted from localization studies
Oligonucleotide primers used in this study
| Primer pair | RS | Sequence (5’➔3′) | Application |
|---|---|---|---|
| bb0173T- | NdeI | ACG C | Amplification of |
| bb0173T- | XhoI | ACG C | |
| bb0173cDNA-F(nt249–272) | GAA GAT GAT ACA TCT TAG TGC TGG | Amplification of bb0173 cDNA from RNA | |
| bb0173cDNA-R(nt725–749) | CTT CCC TGA TAA AAT TTT CCA GAT | ||
| bb0173TM1-SpeI-F | SpeI | ACG C | Amplification of the first putative |
| bb0173TM1-KpnI-R | KpnI | ACG C | |
| bb0173TM1–2-SpeI-F | SpeI | ACG C | Amplification of the second putative |
| bb0173TM2-KpnI-R | KpnI | ACG C | |
| bb0173TM2b-SpeI-F | SpeI | ACG C | Amplification of the third putative |
| bb0173TM2b-KpnI-R | KpnI | AGC C | |
| bb0173TM3-SpeI-F | SpeI | ACG C | Amplification of the fourth putative |
| bb0173TM3-KpnI-R | KpnI | ACG C | |
| bb0173-NcoI-F.1 | NcoI | ACG CCC ATG GAT GTT AAC ATT TAA TGA G | Common amplification start site for truncated insertion constructs |
| T7BB173 | ATA GTA TAA TAC GAC TCA CTA TAG GAA ACC ACC ATG GGC ATG TTA ACA TTT AAT G | Amplification of BB173 with T7 promoter | |
| TM1 NST BB173 | TTA TCA GGA CAT CAT GGT GCT GTT ATA ATC CTT AAG TTT TAA | Amplification of BB173 56mer adding C-tag NST | |
| TM1 QST BB173 | TTA TCA GGA CAT CAT GGT GCT CTG ATA ATC CTT AAG TTT TAA | Amplification of BB173 56mer adding C-tag QSTMMS | |
| TM2 NST BB173 | TTA TCA GGA CAT CAT GGT GCT GTT AAT ATC ATC TAG CTT TT | Amplification of BB173 162mer adding C-tag NST | |
| TM2 QST BB173 | TTA TCA GGA CAT CAT GGT GCT CTG AAT ATC ATC TAG CTT TT | Amplification of BB173 162mer adding C-tag QSTMMS | |
| TM3 NST BB173 | TTA TCA GGA CAT CAT GGT GCT ATT AAG CAT ACT AGG ATC | Amplification of BB173 278mer adding C-tag NST | |
| TM3 QST BB173 | TTA TCA GGA CAT CAT GGT GCT CTG AAG CAT ACT AGG ATC | Amplification of BB173 278mer adding C-tag QSTMMS | |
| TM 4 NST BB173 | TTA TCA GGA CAT CAT GGT GCT GTT CCC GGA CAT GCT GCC CAT TAG TAT CTC TTT TAA GAA | Amplification of BB173 341-mer (full length) adding C-tag NST | |
| TM 4 QST BB173 | TTA TCA GGA CAT CAT GGT GCT CTG CCC GGA CAT GCT GCC CAT TAG TAT CTC TTT TAA GA | Amplification of BB173 341-mer (full length) adding C-tag QSTMMS | |
| TM2 NST BB173 | TTA TCA GGA CAT CAT GGT GCT GTT AAT ATC ATC TAG CTT TT | Amplification of BB173 162mer adding C-tag NST | |
| TM2 QST BB173 | TTA TCA GGA CAT CAT GGT GCT CTG AAT ATC ATC TAG CTT TT | Amplification of BB173 162mer adding C-tag QSTMMS | |
| TM3 NST BB173 | TTA TCA GGA CAT CAT GGT GCT ATT AAG CAT ACT AGG ATC | Amplification of BB173 278mer adding C-tag NST | |
| TM3 QST BB173 | TTA TCA GGA CAT CAT GGT GCT CTG AAG CAT ACT AGG ATC | Amplification of BB173 278mer adding C-tag QSTMMS | |
| bb0170 qPCR F | GTT AAA CCG ATT CCT GGA GAG | Amplification of | |
| bb0170 qPCR R | CAG CCA AAA CTT GAT GCT GC | ||
| bb0171 qPCR F | AAA TCC ATG TCT TTA ATG | Amplification of | |
| bb0171 qPCR R | AAC CCT CTC AAG ATT TTC | ||
| bb0172 qPCR F | TAT GGG GAC AAT TCT TAT ATT CAA | Amplification of | |
| bb0172 qPCR R | CAA TCC CAA CCA CAA AAC TTT CCA | ||
| bb0173 qPCR F | ATT TAA TGA GCC TTT ATA TTT GTT TTT A | Amplification of | |
| bb0173 qPCR R | GAT CCA TAA TAT AAA TAT CAT CTA GCT T | ||
| bb0174 qPCR F | GAT GGT GAA GAG TTT TCC | Amplification of | |
| bb0174 qPCR R | TTC TGT TGT AGT GAT TGC | ||
| bb0175 qPCR F | TTT CAT GAG TTT AGG CCG | Amplification of | |
| bb0175 qPCR R | TGT TGA CTT GCT AAA CCC | ||
| bb0176 qPCR F | TTA CTT GAA GGG GTT CCG | Amplification of | |
| bb0176 qPCR R | ATC CCT TTC ACG GAG TGC | ||
| rpoN qPCR F | TTG TAC CCC ATT CGC ATT TT | Amplification of | |
| rpoN qPCR R | GTG AAA ACC CCC AAA AAC AA | ||
| rpoS qPCR F | TTG GGC GAT TTT TCT TCT TC | Amplification of | |
| rpoS qPCR R | TGC GGG TAA AGG GTT AAA AA | ||
| rrp2 qPCR F | TGT AGC TTC TCC CCC AAC AC | Amplification of | |
| rrp2 qPCR R | TTT TGG CCA TGA AAA AGG AG | ||
| bb0420QF | TGG CAA GTC GAA TAC CCT CT | Amplification of | |
| bb0420QR | TGT TCG ATT TTA TTG GGA TGC | ||
| bb0419F-RT | TTG AGG TTG CAA CAA ATG GA | Amplification of | |
| bb0410R-RT | CGG GAT CGC TTT TTA GCT TT |
Bacterial strains and plasmids used in this study
| Bacterial strain or plasmid | Genotype | Source |
|---|---|---|
|
| cp9−, wild type | Rocky Mountain Labs [ |
|
| ||
| OneShot Top10 | Cloning host; F−
| Invitrogen |
| Rosetta (DE3)pLysS | Expression host; F−
| Novagen |
| Plasmids | ||
| pCS1–5 | pCR2.1( | This study |
| pCS1–9 | pET23a( | This study |